10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission file number  001-41459

SILGAN HOLDINGS INC.

(Exact name of Registrant as specified in its charter)

Delaware		06-1269834
(State or other jurisdiction		(I.R.S. Employer
of incorporation or organization)		Identification No.)
4 Landmark Square
Stamford,	Connecticut	06901
(Address of principal executive offices)		(Zip Code)

(203) 975-7110

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	SLGN	New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).  Yes ☒   No ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No ☒

As of April 28, 2023, the number of shares outstanding of the Registrant’s common stock was 110,252,446.

-1-

SILGAN HOLDINGS INC.
TABLE OF CONTENTS
	Page No.
Part I.  Financial Information	3
Item 1.    Financial Statements	3
Condensed Consolidated Balance Sheets at March 31, 2023 and 2022 and December 31, 2022	3
Condensed Consolidated Statements of Income for the three months ended March 31, 2023 and 2022	4
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2023 and 2022	5
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022	6
Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2023 and 2022	7
Notes to Condensed Consolidated Financial Statements	8
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.    Quantitative and Qualitative Disclosures About Market Risk	25
Item 4.    Controls and Procedures	25
Part II.  Other Information	26
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds	26
Item 6.    Exhibits	27
Signatures	28

-2-

Part I. Financial Information

Item 1. Financial Statements

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(unaudited)		(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	501,060	$	259,564	$	585,622
Trade accounts receivable, net	936,048		852,876		657,968
Inventories	1,055,079		1,018,685		769,403
Prepaid expenses and other current assets	132,822		150,646		119,659
Total current assets	2,625,009		2,281,771		2,132,652
Property, plant and equipment, net	1,930,003		1,979,681		1,931,497
Goodwill	2,001,753		2,024,340		1,984,952
Other intangible assets, net	755,883		817,450		763,812
Other assets, net	549,074		607,168		532,844
	$	7,861,722	$	7,710,410	$	7,345,757
Liabilities and Stockholders’ Equity
Current liabilities:
Revolving loans and current portion of long-term debt	$	784,795	$	539,134	$	80,061
Trade accounts payable	716,487		850,532		974,030
Accrued payroll and related costs	101,881		109,096		98,914
Accrued liabilities	240,952		218,194		284,855
Total current liabilities	1,844,115		1,716,956		1,437,860
Long-term debt	3,370,346		3,445,633		3,345,381
Deferred income taxes	389,010		433,843		388,677
Other liabilities	476,961		475,739		455,583
Stockholders’ equity:
Common stock	1,751		1,751		1,751
Paid-in capital	342,157		328,201		339,839
Retained earnings	3,013,104		2,758,697		2,961,079
Accumulated other comprehensive loss	(324,570)		(244,642)		(345,310)
Treasury stock	(1,251,152)		(1,205,768)		(1,239,103)
Total stockholders’ equity	1,781,290		1,638,239		1,718,256
	$	7,861,722	$	7,710,410	$	7,345,757

See accompanying notes.

-3-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the three months ended March 31, 2023 and 2022

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

	2023		2022
Net sales	$	1,418,281	$	1,441,886
Cost of goods sold	1,180,316		1,208,433
Gross profit	237,965		233,453
Selling, general and administrative expenses	101,330		100,011
Rationalization charges	4,121		1,379
Other pension and postretirement expense (income)	1,286		(11,329)
Income before interest and income taxes	131,228		143,392
Interest and other debt expense before loss on     early extinguishment of debt	36,766		29,349
Loss on early extinguishment of debt	—		1,481
Interest and other debt expense	36,766		30,830
Income before income taxes	94,462		112,562
Provision for income taxes	22,433		27,687
Net income	$	72,029	$	84,875
Earnings per share:
Basic net income per share	$	0.65	$	0.77
Diluted net income per share	$	0.65	$	0.76
Weighted average number of shares:
Basic	110,219		110,600
Effect of dilutive securities	630		793
Diluted	110,849		111,393

See accompanying notes.

-4-

 SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three months ended March 31, 2023 and 2022

(Dollars in thousands)

(Unaudited)

	2023		2022
Net income	$	72,029	$	84,875
Other comprehensive income (loss), net of tax:
Changes in net prior service credit and actuarial losses	2,306		499
Change in fair value of derivatives	(1,287)		2,337
Foreign currency translation	19,721		12,350
Other comprehensive income	20,740		15,186
Comprehensive income	$	92,769	$	100,061

See accompanying notes.

-5-

 SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2023 and 2022

(Dollars in thousands)

(Unaudited)

	2023		2022
Cash flows provided by (used in) operating activities:
Net income	$	72,029	$	84,875
Adjustments to reconcile net income to net cash     provided by (used in) operating activities:
Depreciation and amortization	66,176		69,067
Rationalization charges	4,121		1,379
Stock compensation expense	3,681		4,879
Loss on early extinguishment of debt	—		1,481
Other changes that provided (used) cash, net of effects from acquisitions:
Trade accounts receivable, net	(271,224)		(141,113)
Inventories	(279,982)		(222,137)
Trade accounts payable	(176,147)		(29,881)
Accrued liabilities	(49,812)		(23,291)
Other, net	(616)		(12,660)
Net cash (used in) operating activities	(631,774)		(267,401)
Cash flows provided by (used in) investing activities:
Purchase of businesses, net of cash acquired	—		(1,333)
Capital expenditures	(67,871)		(68,491)
Other, net	880		(203)
Net cash (used in) investing activities	(66,991)		(70,027)
Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	783,454		544,624
Repayments under revolving loans	(29,100)		(24,408)
Proceeds from issuance of long-term debt	2,146		—
Repayments of long-term debt	(50,705)		(300,000)
Changes in outstanding checks - principally vendors	(61,433)		(225,863)
Dividends paid on common stock	(20,575)		(18,722)
Repurchase of common stock	(13,412)		(11,474)
Net cash provided by (used in) financing activities	610,375		(35,843)
Effect of exchange rate changes on cash and cash equivalents	3,828		1,396
Cash and cash equivalents:
Net (decrease)	(84,562)		(371,875)
Balance at beginning of year	585,622		631,439
Balance at end of period	$	501,060	$	259,564
Interest paid, net	$	34,764	$	33,116
Income taxes paid, net	20,086		6,718

See accompanying notes.

-6-

SILGAN HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the three months ended March 31, 2023 and 2022

(Dollars and shares in thousands, except per share amounts)

(Unaudited)

	2023		2022
Common stock - shares outstanding
Balance at beginning of period	110,079		110,410
Net issuance of treasury stock for vested restricted stock units	266		390
Repurchases of common stock	(93)		—
Balance at end of period	110,252		110,800
Common stock - par value
Balance at beginning and end of period	$	1,751	$	1,751
Paid-in capital
Balance at beginning of period	339,839		325,448
Stock compensation expense	3,681		4,879
Net issuance of treasury stock for vested restricted stock units	(1,363)		(2,126)
Balance at end of period	342,157		328,201
Retained earnings
Balance at beginning of period	2,961,079		2,691,745
Net income	72,029		84,875
Dividends declared on common stock	(20,004)		(17,923)
Balance at end of period	3,013,104		2,758,697
Accumulated other comprehensive loss
Balance at beginning of period	(345,310)		(259,828)
Other comprehensive income	20,740		15,186
Balance at end of period	(324,570)		(244,642)
Treasury stock
Balance at beginning of period	(1,239,103)		(1,196,420)
Net issuance of treasury stock for vested restricted stock units	(7,249)		(9,348)
Repurchases of common stock	(4,800)		—
Balance at end of period	(1,251,152)		(1,205,768)
Total stockholders’ equity	$	1,781,290	$	1,638,239
Dividends declared on common stock per share	$	0.18	$	0.16

See accompanying notes.

-7-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 1.               Significant Accounting Policies

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2022 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.

Note 2.               Revenue

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Dispensing and Specialty Closures	$	579,932	$	597,927
Metal Containers	670,096		650,726
Custom Containers	168,253		193,233
	$	1,418,281	$	1,441,886

Revenues by geography for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
North America	$	1,056,526	$	1,086,224
Europe and other	361,755		355,662
	$	1,418,281	$	1,441,886

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $108.5 million, $99.1 million, and $110.2 million as of March 31, 2023 and 2022 and December 31, 2022, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets.

-8-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 3.               Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Rationalization charges by segment for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Dispensing and Specialty Closures	$	114	$	—
Metal Containers	3,903		1,274
Custom Containers	104		105
	$	4,121	$	1,379

Activity in reserves for our rationalization plans were as follows:

	Employee Severance and Benefits		Plant Exit Costs		Total
	(Dollars in thousands)
Balance at December 31, 2022	$	31,641	$	159	$	31,800
Charged to expense	1,797		2,324		4,121
Utilized and currency translation	(2,813)		(2,319)		(5,132)
Balance at March 31, 2023	$	30,625	$	164	$	30,789

Rationalization reserves as of March 31, 2023 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $3.2 million and other liabilities of $27.6 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $1.7 million and $5.4 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.9 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $0.8 million in 2023 and $2.6 million annually thereafter through 2040.

-9-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 4.               Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders’ Equity.  Amounts included in accumulated other comprehensive loss, net of tax, were as follows:

 

	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2022	$	(156,733)	$	(772)	$	(187,805)	$	(345,310)
Other comprehensive income before reclassifications	—		(1,714)		19,721		18,007
Amounts reclassified from accumulated other     comprehensive loss	2,306		427		—		2,733
Other comprehensive income	2,306		(1,287)		19,721		20,740
Balance at March 31, 2023	$	(154,427)	$	(2,059)	$	(168,084)	$	(324,570)

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three months ended March 31, 2023 were net (losses) of $(2.6) million, excluding income tax benefits of $0.3 million. These net (losses) consisted of amortization of net actuarial (losses) of $(2.8) million and amortization of net prior service credit of $0.2 million. Amortization of net actuarial losses and net prior service credit was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 10 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three months ended March 31, 2023 were not significant.

Other comprehensive loss before reclassifications related to foreign currency translation for the three months ended March 31, 2023 consisted of (i) foreign currency gains related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $25.6 million, (ii) foreign currency gains related to intra-entity foreign currency transactions that are of a long-term investment nature of $0.8 million, and (iii) foreign currency (losses) related to our net investment hedges of $(8.8) million, excluding an income tax benefit of $2.1 million. See Note 7 for further discussion.

-10-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 5.               Inventories

Inventories consisted of the following: 

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(Dollars in thousands)
Raw materials	$	498,580	$	295,713	$	409,349
Work-in-process	254,373		263,878		218,691
Finished goods	630,233		607,087		469,212
Other	16,205		14,787		16,463
	1,399,391		1,181,465		1,113,715
Adjustment to value inventory at cost on the LIFO method	(344,312)		(162,780)		(344,312)
	$	1,055,079	$	1,018,685	$	769,403

Note 6.               Long-Term Debt

Long-term debt consisted of the following: 

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	755,000	$	508,000	$	—
U.S. term loans	950,000		1,000,000		1,000,000
Other foreign bank revolving and term loans	51,840		50,014		49,673
Total bank debt	1,756,840		1,558,014		1,049,673
3¼% Senior Notes	706,160		723,190		693,680
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	543,200		556,300		533,600
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	65,050		67,714		65,667
Total debt - principal	4,171,250		4,005,218		3,442,620
Less unamortized debt issuance costs and debt discount	16,109		20,451		17,178
Total debt	4,155,141		3,984,767		3,425,442
Less current portion	784,795		539,134		80,061
	$	3,370,346	$	3,445,633	$	3,345,381

At March 31, 2023, the current portion of long-term debt consisted of $755.0 million of U.S. revolving loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $27.4 million of other foreign bank revolving and term loans and $2.4 million of finance leases.

-11-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 7.               Financial Instruments

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2023:

	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	501,060	$	501,060
Liabilities:
Bank debt	$	1,756,840	$	1,756,840
3¼% Senior Notes	706,160		689,558
4⅛% Senior Notes	599,346		564,720
2¼% Senior Notes	543,200		459,971
1.4% Senior Secured Notes	499,836		445,715

Fair Value Measurements

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Financial Instruments Measured at Fair Value

The financial assets and liabilities that were measured on a recurring basis at March 31, 2023 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

Financial Instruments Not Measured at Fair Value

Our bank debt, 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were estimated based on quoted market prices, a Level 1 input.

Derivative Instruments and Hedging Activities

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

-12-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss. 

Interest Rate Swap Agreements

We had two U.S. dollar interest rate swap agreements, each for $50.0 million notional principal amount, to manage a portion of our exposure to interest rate fluctuations, with a fixed rate of 2.878 percent, that matured on March 24, 2023. In March 2023, we entered into four U.S. dollar interest rate swap agreements, each for $75.0 million notional principal amount, to manage a portion of our exposure to interest rate fluctuations. These agreements have a fixed rate ranging from 3.930 percent to 3.942 percent, mature on April 3, 2026 and were entered into with financial institutions which are expected to fully perform under the terms thereof. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2023. The total fair value of our interest rate swaps agreements in effect at March 31, 2023 was not significant.

Natural Gas Swap Agreements

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2023. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at March 31, 2023 was not significant.

Foreign Currency Exchange Rate Risk

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the 3¼% Senior Notes which are Euro denominated. Foreign currency (losses) related to our net investment hedges included in accumulated other comprehensive loss for the three months ended March 31, 2023 were $(8.8) million.

-13-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 8.               Commitments and Contingencies

We are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

Note 9.               Supply Chain Finance Program

We have a supply chain finance (“SCF”) program with a major global financial institution. Under this SCF program, qualifying suppliers may elect, but are not obligated, to sell their receivables from us to such financial institution. We agree to pay the financial institution the stated amount of invoices from our suppliers electing to participate on the original maturity dates of the invoices. We may terminate our agreement with the financial institution upon at least 30 days’ notice, and the financial institution may terminate our agreement upon at least 10 days’ notice. Additionally, suppliers who elect to participate in this SCF program may terminate their participation upon at least 30 days’ notice. The suppliers' invoices sold under this SCF program can be outstanding up to 210 days from the invoice date. Suppliers’ invoices included in this SCF program were $318.4 million, $372.2 million and $346.8 million at March 31, 2023 and 2022 and December 31, 2022, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

Note 10.               Retirement Benefits

The components of the net periodic pension benefit cost (credit) for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Service cost	$	2,229	$	3,300
Interest cost	8,709		5,159
Expected return on plan assets	(10,189)		(17,314)
Amortization of prior service cost	28		55
Amortization of actuarial losses	2,945		1,155
Net periodic benefit cost (credit)	$	3,722	$	(7,645)

The components of the net periodic other postretirement benefit credit for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Service cost	$	14	$	25
Interest cost	189		109
Amortization of prior service credit	(235)		(416)
Amortization of actuarial gains	(161)		(77)
Net periodic benefit credit	$	(193)	$	(359)

Note 11.               Income Taxes

Silgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2021 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2022 and 2023 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

-14-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Note 12.               Treasury Stock

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. During the three months ended March 31, 2023, we repurchased an aggregate of 92,996 shares of our common stock at an average price per share of $51.60, for a total purchase price of $4.8 million. At March 31, 2023, we had approximately $263.1 million remaining under this authorization for the repurchase of our common stock.

During the first three months of 2023, we issued 427,763 treasury shares which had an average cost of $3.19 per share for restricted stock units that vested during the period that had been previously issued under the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan. In accordance with the applicable agreements for such restricted stock units, we repurchased 161,328 shares of our common stock at an average cost of $53.38 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of March 31, 2023, 64,860,050 shares of our common stock were held in treasury.

Note 13.             Segment Information

We evaluate performance of our business segments and allocate resources based on the adjusted EBIT of our business segments. Adjusted EBIT is not a defined term under GAAP. We define adjusted EBIT as income before interest and income taxes excluding acquired intangible asset amortization expense, other pension expense (income) for U.S. pension plans, rationalization charges, the impact from charges for the write-up of acquired inventory required under purchase accounting, the charge for the European Commission settlement and costs attributed to announced acquisitions. We began using adjusted EBIT in 2023. Previously, we used segment income, without any adjustments, for our business segments. We have provided adjusted EBIT for 2022 below for comparative purposes. Adjusted EBIT should not be considered in isolation or as a substitute for income before interest and income taxes or any other financial data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies.

Reportable segment information for the three months ended March 31 was as follows:

	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three months ended March 31, 2023
Net sales	$	579,932	$	670,096	$	168,253	$	—	$	1,418,281
Adjusted EBIT	82,936		52,400		20,034		(5,966)		149,404
Depreciation	24,759		17,988		8,835		40		51,622
Three months ended March 31, 2022
Net sales	$	597,927	$	650,726	$	193,233	$	—	$	1,441,886
Adjusted EBIT	96,528		32,951		23,364		(6,624)		146,219
Depreciation	24,661		20,731		8,743		42		54,177

-15-

SILGAN HOLDINGS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Information at March 31, 2023 and 2022 and for the

three months then ended is unaudited)

Total adjusted EBIT is reconciled to income before income taxes for the three months ended March 31 as follows:

	2023		2022
	(Dollars in thousands)
Total adjusted EBIT	$	149,404	$	146,219
Less:
Acquired intangible asset amortization expense	13,221		13,430
Other pension expense (income) for U.S. pension plans	834		(11,982)
Rationalization charges	4,121		1,379
Income before interest and income taxes	131,228		143,392
Less interest and other debt expense	36,766		30,830
Income before income taxes	$	94,462	$	112,562

Net sales and adjusted EBIT of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual adjusted EBIT during that quarter.

-16-

Item 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Statements included in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q that are not historical facts are “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Securities Exchange Act of 1934, as amended.  Such forward-looking statements are made based upon management’s expectations and beliefs concerning future events impacting us and therefore involve a number of uncertainties and risks, including, but not limited to, those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in our other filings with the Securities and Exchange Commission.  As a result, the actual results of our operations or our financial condition could differ materially from those expressed or implied in these forward-looking statements.

General

We are a leading manufacturer of sustainable rigid packaging solutions for the world's essential consumer goods products.  We currently produce dispensing and specialty closures for food, beverage, health care, garden, home, personal care, fragrance and beauty products; steel and aluminum containers for human and pet food and general line products; and custom designed plastic containers for personal care, food, health care, pharmaceutical, household and industrial chemical, pet food and care, agricultural, automotive and marine chemical products. We are a leading worldwide manufacturer of dispensing and specialty closures, a leading manufacturer of metal containers in North America and Europe, and a leading manufacturer of custom containers in North America for a variety of markets.

Our objective is to increase shareholder value by efficiently deploying capital and management resources to grow our business, reduce operating costs and build sustainable competitive positions, or franchises, and to complete acquisitions that generate attractive cash returns.  We have grown our net sales and income from operations largely through acquisitions but also through internal growth, and we continue to evaluate acquisition opportunities in the consumer goods packaging market. If acquisition opportunities are not identified over a longer period of time, we may use our cash flow to repay debt, repurchase shares of our common stock or increase dividends to our stockholders or for other permitted purposes.

-17-

RESULTS OF OPERATIONS

The following table sets forth certain unaudited income statement data expressed as a percentage of net sales for the three months ended March 31:

	2023		2022
Net sales
Dispensing and Specialty Closures	40.9	%	41.5	%
Metal Containers	47.2		45.1
Custom Containers	11.9		13.4
Consolidated	100.0		100.0
Cost of goods sold	83.2		83.8
Gross profit	16.8		16.2
Selling, general and administrative expenses	7.1		7.0
Rationalization charges	0.3		0.1
Other pension and postretirement expense (income)	0.1		(0.8)
Income before interest and income taxes	9.3		9.9
Interest and other debt expense	2.6		2.1
Income before income taxes	6.7		7.8
Provision for income taxes	1.6		1.9
Net income	5.1	%	5.9	%

Summary unaudited results of operations for the three months ended March 31 are provided below.

	2023		2022
	(dollars in millions)
Net sales
Dispensing and Specialty Closures	$	579.9	$	597.9
Metal Containers	670.1		650.7
Custom Containers	168.3		193.3
Consolidated	$	1,418.3	$	1,441.9
Income before interest and income taxes
Dispensing and Specialty Closures	$	70.9	$	87.3
Metal Containers	47.8		38.0
Custom Containers	18.5		24.7
Corporate	(6.0)		(6.6)
Consolidated	$	131.2	$	143.4

Three Months Ended March 31, 2023 Compared with Three Months Ended March 31, 2022

Net Sales.  Consolidated net sales were $1.42 billion in the first quarter of 2023, a decrease of $23.6 million, or 1.6 percent, as compared to the first quarter of 2022 primarily due to lower volumes in the dispensing and specialty closures and custom containers segments, the impact from unfavorable foreign currency translation, non-recurring net sales associated with Russia in 2022, lower average selling prices due primarily to the pass through of lower resin costs in the custom containers segment and a less favorable mix of products sold in the metal container segment. These decreases were partially offset by higher selling prices primarily related to inflation in other manufacturing costs in each of the segments, higher unit volumes in the metal containers segment and a more favorable mix of products sold in the dispensing and specialty closures segment.

Gross Profit.  Gross profit margin increased 0.6 percentage points to 16.8 percent in the first quarter of 2023 as compared to the same period in 2022 for the reasons discussed below in "Income before Interest and Income Taxes."

-18-

Selling, General and Administrative Expenses.  Selling, general and administrative expenses as a percentage of consolidated net sales increased to 7.1 percent in the first quarter of 2023 as compared to 7.0 percent in the same period in 2022. Selling, general and administrative expenses increased $1.3 million to $101.3 million for the first quarter of 2023 as compared to $100.0 million for the same period in 2022.

Other pension and postretirement expense (income). Other pension and postretirement expense in the first quarter of 2023 was $1.3 million, while other pension and postretirement (income) in the first quarter of 2022 was $(11.3) million. This period -over-period change in other pension and postretirement expense (income) was the result of a lower pension asset balance in 2023 due to a lower rate of return on assets in 2022, higher pension plan interest cost and a decrease in the expected long-term rate of return on U.S. pension plan assets in 2023 from 2022. The expected long-term rate of return on pension plan assets was decreased from 6.9 percent in 2022 to 5.5 percent in 2023 due to planned changes in investment allocations for our U.S. pension plans, which are overfunded with plan assets of approximately 129 percent of projected benefit obligations at December 31, 2022, to a liability driven investment strategy that more closely matches plan assets with plan liabilities primarily using long duration bonds.

Income before Interest and Income Taxes.  Income before interest and income taxes for the first quarter of 2023 decreased by $12.2 million to $131.2 million as compared to $143.4 million in the first quarter of 2022, and margins decreased to 9.3 percent from 9.9 percent over the same periods. The decrease in income before interest and income taxes was primarily the result of other pension and postretirement expense in the current year period as compared to other pension and postretirement income in the prior year period, the unfavorable impact in the current year period from the delayed pass through of higher resin costs as compared to the favorable impact in the prior year period from the delayed pass through of lower resin costs in the dispensing and specialty closures segment, the favorable impact in the prior year period from an inventory management program in the dispensing and specialty closures segment, lower volumes in the custom containers and dispensing and specialty closures segments, a less favorable mix of products sold in the metal containers segment, higher rationalization charges and the impact of unfavorable foreign currency translation. These decreases were partially offset by the favorable impact in the current year period from the lagged contractual pass through of inflation in other manufacturing costs in the metal containers segment, a more favorable mix of products sold in the dispensing and specialty closures segment, higher unit volumes in the metal containers segment, and cost savings and higher prices primarily related to inflation in other manufacturing costs in the custom containers business. Rationalization charges were $4.1 million and $1.4 million in the first quarters of 2023 and 2022, respectively.

Interest and Other Debt Expense. Interest and other debt expense for the first quarter of 2023 increased $6.0 million to $36.8 million as compared to $30.8 million in the same period in 2022. This increase was primarily due to higher weighted average interest rates.

Provision for Income Taxes. The effective tax rates were 23.8 percent and 24.6 percent for the first quarters of 2023 and 2022, respectively. The effective tax rate for the first quarter of 2023 was favorably impacted by higher income generated in more favorable tax jurisdictions.

Non-GAAP Measures

Generally accepted accounting principles in the United States are commonly referred to as GAAP. A non-GAAP financial measure is generally defined as a financial measure that purports to measure financial performance, financial position or liquidity but excludes or includes amounts that could not be so adjusted in the most comparable GAAP measure. Adjusted EBIT and adjusted EBIT margin are unaudited supplemental measures of financial performance that the Company uses, which are not required by, or presented in accordance with, GAAP and therefore are non-GAAP financial measures. These non-GAAP financial measures should not be considered as alternatives to income before interest and income taxes or any other measures derived in accordance with GAAP. Such non-GAAP financial measures should not be considered in isolation or as a substitute for any financial data prepared in accordance with GAAP and may not be comparable to similarly titled measures used by other companies. The Company uses such non-GAAP financial measures because it considers them to be important and useful supplemental measures of its and its segments’ financial performance which provide a more complete understanding of the Company and its segments than could be obtained absent such non-GAAP financial measures. The Company believes that it is important and useful to present these non-GAAP financial measures because they allow for a better period-over-period comparison of results by removing the impact of items that, in management’s view, do not reflect the Company’s or its segments’ core operating performance. Management uses these non-GAAP financial measures to review and analyze the operating performance of the Company and its segments. Investors and others are urged to review and consider carefully the adjustments made by management to the most comparable GAAP financial measure to arrive at these non-GAAP financial measures.

-19-

Adjusted EBIT, a non-GAAP financial measure, means income before interest and income taxes excluding, as applicable, acquired intangible asset amortization expense, other pension expense (income) for U.S. pension plans, rationalization charges, the impact from charges for the write-up of acquired inventory required under purchase accounting, the charge for the European Commission settlement and costs attributed to announced acquisitions. Adjusted EBIT margin, a non-GAAP financial measure, means adjusted EBIT divided by segment net sales.

Acquired intangible asset amortization expense is a non-cash expense related to acquired operations that management believes is not indicative of the on-going performance of the acquired operations. Since the Company’s U.S. pension plans are significantly over funded and have no required cash contributions for the foreseeable future based on current regulations, management views other pension expense (income) from the Company’s U.S. pension plans, which excludes service costs, as not reflective of the operational performance of the Company or its segments. While rationalization costs are incurred on a regular basis, management views these costs more as an investment to generate savings rather than period costs. The write-up of acquired inventory required under purchase accounting is viewed by management as part of the acquisition and is a non-cash charge that is not considered to be indicative of the on-going performance of the acquired operations. The charge for the European Commission settlement is nonrecurring and non-operational and relates to prior years and is not indicative of the on-going cost structure of the Company or its segments. Costs attributed to announced acquisitions consist of third party fees and expenses that are viewed by management as part of the acquisition and not indicative of the on-going cost structure of the Company. A reconciliation of such non-GAAP financial measures is provided below for the three months ended March 31:

	2023		2022
	(dollars in millions)
Dispensing and Specialty Closures:
Income before interest and income taxes (EBIT)	$	70.9	$	87.3
Acquired intangible asset amortization expense	11.8		12.0
Other pension expense (income) for U.S. pension plans	0.1		(2.8)
Rationalization charges	0.1		—
Adjusted EBIT	$	82.9	$	96.5
Metal Containers
Income before interest and income taxes (EBIT)	$	47.8	$	38.0
Acquired intangible asset amortization expense	0.3		0.3
Other pension expense (income) for U.S. pension plans	0.4		(6.7)
Rationalization charges	3.9		1.3
Adjusted EBIT	$	52.4	$	32.9
Custom Containers
Income before interest and income taxes (EBIT)	$	18.5	$	24.7
Acquired intangible asset amortization expense	1.1		1.1
Other pension expense (income) for U.S. pension plans	0.4		(2.5)
Rationalization charges	0.1		0.1
Adjusted EBIT	$	20.1	$	23.4
Corporate
Loss before interest and income taxes (EBIT)	$	(6.0)	$	(6.6)
Adjusted EBIT	$	(6.0)	$	(6.6)
Total adjusted EBIT	$	149.4	$	146.2

-20-

Dispensing and Specialty Closures Segment

	2023			2022
	(dollars in millions)
Net sales	$	579.9		$	597.9
Income before interest and income taxes (EBIT)	70.9			87.3
Income before interest and income taxes margin (EBIT margin)	12.2		%	14.6		%
Adjusted EBIT	$	82.9		$	96.5
Adjusted EBIT margin	14.3		%	16.1		%

Net sales for the dispensing and specialty closures segment decreased $18.0 million, or 3.0 percent, in the first quarter of 2023 as compared to the same period in 2022. This decrease was primarily the result of lower unit volumes of approximately six percent, the impact of unfavorable foreign currency translation of approximately $12 million and non-recurring net sales associated with Russia in 2022 of $4.0 million, partially offset by a more favorable mix of products sold and higher selling prices primarily related to inflation in other manufacturing costs. The decrease in unit volumes was principally the result of lower volumes for closures for food and beverage markets due to the timing of customer purchases, partially offset by volume growth in higher margin dispensing products.

Adjusted EBIT of the dispensing and specialty closures segment for the first quarter of 2023 decreased $13.6 million as compared to the same period in 2022, and adjusted EBIT margin decreased to 14.3 percent from 16.1 percent over the same periods. The decrease in adjusted EBIT was primarily due to the unfavorable impact in the current year period from the delayed pass through of higher resin costs as compared to the favorable impact in the prior year period from the delayed pass through of lower resin costs, the favorable impact in the prior year period from an inventory management program, lower unit volumes and the impact of unfavorable foreign currency translation, partially offset by a more favorable mix of products sold.

Metal Containers Segment

	2023			2022
	(dollars in millions)
Net sales	$	670.1		$	650.7
Income before interest and income taxes (EBIT)	47.8			38.0
Income before interest and income taxes margin (EBIT margin)	7.1		%	5.8		%
Adjusted EBIT	$	52.4		$	32.9
Adjusted EBIT margin	7.8		%	5.1		%

Net sales for the metal containers segment increased $19.4 million, or 3.0 percent, in the first quarter of 2023 as compared to the same period in 2022. This increase was primarily the result of higher unit volumes of approximately three percent and higher average selling prices due to the lagged contractual pass through of inflation in other manufacturing costs, partially offset by a less favorable mix of products sold, non-recurring net sales associated with Russia in 2022 of $5.5 million and the impact of unfavorable foreign currency translation of approximately $4 million. The increase in unit volumes was principally the result of higher volumes primarily for pet food.

Adjusted EBIT of the metal containers segment for the first quarter of 2023 increased $19.5 million as compared to the same period in 2022, and adjusted EBIT margin increased to 7.8 percent from 5.1 percent for the same periods. The increase in adjusted EBIT was primarily due to higher average selling prices due to the lagged contractual pass through of inflation in other manufacturing costs and higher unit volumes, partially offset by a less favorable mix of products sold and the impact of unfavorable foreign currency translation.

-21-

Custom Containers Segment

	2023			2022
	(dollars in millions)
Net sales	$	168.3		$	193.3
Income before interest and income taxes (EBIT)	18.5			24.7
Income before interest and income taxes margin (EBIT margin)	11.0		%	12.8		%
Adjusted EBIT	$	20.1		$	23.4
Adjusted EBIT margin	11.9		%	12.1		%

Net sales for the custom containers segment decreased $25.0 million, or 12.9 percent, in the first quarter of 2023 as compared to the same period in 2022. This decrease was principally due to lower volumes of approximately ten percent, the unfavorable impact in the current year period from the pass through of lower resin costs and the impact of unfavorable foreign currency translation of approximately $2 million, partially offset by price increases primarily related to inflation in other manufacturing costs. The decline in volumes was primarily due to the exiting of lower margin business that did not meet reinvestment criteria.

Adjusted EBIT of the custom containers segment for the first quarter of 2023 decreased $3.3 million as compared to the same period in 2022, and adjusted EBIT margin decreased to 11.9 percent from 12.1 percent over the same periods. The decrease in adjusted EBIT was primarily attributable to lower volumes, partially offset by cost savings and higher prices primarily related to inflation in other manufacturing costs.

CAPITAL RESOURCES AND LIQUIDITY

Our principal sources of liquidity have been net cash from operating activities and borrowings under our debt instruments, including our senior secured credit facility. Our liquidity requirements arise from our obligations under the indebtedness incurred in connection with our acquisitions and the refinancing of that indebtedness, capital investment in new and existing equipment, the funding of our seasonal working capital needs and other general corporate uses.

For the three months ended March 31, 2023, we used net borrowings of revolving loans and proceeds from other foreign long-term debt of an aggregate of $756.5 million and cash and cash equivalents of $84.6 million (including the positive effect of exchange rate changes of $3.8 million) to fund cash used in operations of $631.8 million, net capital expenditures and other investing activities of $67.0 million, decreases in outstanding checks of $61.4 million, the repayment of long-term debt of $50.7 million, dividends paid on our common stock of $20.6 million and repurchases of our common stock of $13.4 million.

For the three months ended March 31, 2022, we used net borrowings of revolving loans of $520.2 million and cash and cash equivalents of $371.9 million (including the positive effect of exchange rate changes of $1.4 million) to fund the redemption of our 4¾% Senior Notes for $300.0 million, cash used in operations of $267.4 million, decreases in outstanding checks of $225.9 million, net capital expenditures and other investing activities of $70.0 million, dividends paid on our common stock of $18.7 million and repurchases of our common stock of $11.5 million.

At March 31, 2023, we had $755.0 million of revolving loans outstanding under the Credit Agreement. After taking into account outstanding letters of credit, the available portion of revolving loans under the Credit Agreement at March 31, 2023 was $724.6 million.

Because we sell metal containers and closures used in fruit and vegetable pack processing, we have seasonal sales. As is common in the industry, we must utilize working capital to build inventory and then carry accounts receivable for some customers beyond the end of the packing season. Due to our seasonal requirements, which generally peak sometime in the summer or early fall, we may incur short-term indebtedness to finance our working capital requirements. Our peak seasonal working capital requirements have historically averaged approximately $350 million. We fund seasonal working capital requirements through revolving loans under the Credit Agreement, other foreign bank loans and cash on hand. We may use the available portion of revolving loans under the Credit Agreement, after taking into account our seasonal needs and outstanding letters of credit, for other general corporate purposes including acquisitions, capital expenditures, dividends, stock repurchases and to refinance or repurchase other debt.

We believe that cash generated from operations and funds from borrowings available under the Credit Agreement and other foreign bank loans will be sufficient to meet our expected operating needs, planned capital expenditures, debt service, tax

-22-

obligations, pension benefit plan contributions, share repurchases and common stock dividends for the foreseeable future. We continue to evaluate acquisition opportunities in the consumer goods packaging market and may incur additional indebtedness, including indebtedness under the Credit Agreement, to finance any such acquisition.

We are in compliance with all financial and operating covenants contained in our financing agreements and believe that we will continue to be in compliance during 2023 with all of these covenants.

Supply Chain Finance Program

We believe that we negotiate the best terms possible with our suppliers, including payment terms. In connection therewith, we initiated a SCF program with a major global financial institution. Under this SCF program, qualifying suppliers may elect, but are not obligated, to sell their receivables from us to such financial institution. A participating supplier negotiates its receivables sale arrangements directly with the financial institution under this SCF program. While we are not party to, and do not participate in the negotiation of, such receivables sale arrangements, such financial institution allows a participating supplier to utilize our creditworthiness in establishing a credit spread in respect of the sale of its receivables from us as well as in establishing other applicable terms. This may provide a supplier with more favorable terms than it would be able to secure on its own. We have no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier elects to participate in this SCF program and reaches an agreement with the financial institution, the supplier independently elects which individual invoices to us that they sell to the financial institution. All of our payments to a participating supplier are paid to the financial institution on the invoice due date under our agreement with such supplier, regardless of whether the individual invoice was sold by the supplier to the financial institution. The financial institution then pays the supplier on the invoice due date under our agreement with such supplier for any invoices not previously sold by the supplier to the financial institution. Amounts due to a supplier that elects to participate in this SCF program are included in accounts payable in our Condensed Consolidated Balance Sheet, and the associated payments are reflected in net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows. Separate from this SCF program, we and suppliers who participate in this SCF program generally maintain the contractual right to require the other party to negotiate in good faith the existing payment terms as a result of changes in market conditions, including changes in interest rates and general market liquidity, or in some cases for any reason. Outstanding trade accounts payables subject to this SCF program were approximately $318.4 million, $372.2 million and $346.8 million at March 31, 2023 and 2022 and December 31, 2022, respectively.

Guaranteed Securities

Each of the 3¼% Senior Notes, the 4⅛% Senior Notes, the 2¼% Senior Notes and the 1.4% Senior Secured Notes were issued by Silgan and are guaranteed by our U.S. subsidiaries that also guarantee our obligations under the Credit Agreement, collectively the Obligor Group.

The following summarized financial information relates to the Obligor Group as of March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023. Intercompany transactions, equity investments and other intercompany activity within the Obligor Group have been eliminated from the summarized financial information. Investments in subsidiaries of Silgan that are not part of the Obligor Group of $1.5 billion and $1.4 billion as of March 31, 2023 and December 31, 2022 are not included in noncurrent assets in the table below.

	March 31, 2023	Dec. 31, 2022
	(Dollars in millions)
Current assets	$1,718.6	$1,247.4
Noncurrent assets	4,043.2	4,028.4
Current liabilities	1,493.8	1,077.7
Noncurrent liabilities	3,946.5	3,911.4

At March 31, 2023 and December 31, 2022, the Obligor Group held current receivables due from other subsidiary companies of $39.2 million and $72.4 million, respectively; long-term notes receivable due from other subsidiary companies of $754.5 million and $730.0 million, respectively; and current payables due to other subsidiary companies of $5.4 million and $7.9 million, respectively.

-23-

	Three months ended March 31, 2023
	(Dollars in millions)
Net sales	$1,020.7
Gross profit	146.6
Net income	45.0

For the three months ended March 31, 2023, net income in the table above excludes income from equity method investments of other subsidiary companies of $27.1 million. For the three months ended March 31, 2023, the Obligor Group recorded the following transactions with other subsidiary companies: sales to such other subsidiary companies of $13.3 million; net credits from such other subsidiary companies of $7.9 million; and net interest income from such other subsidiary companies of $8.5 million. For the three months ended March 31, 2023, the Obligor Group received dividends from other subsidiary companies of $2.4 million.

Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Under our rationalization plans, we made cash payments of $5.1 million and $2.5 million for the three months ended March 31, 2023 and 2022, respectively. Excluding the impact of our withdrawal from the Central States Pension Plan in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $1.7 million and $5.4 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.9 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $0.8 million in 2023 and $2.6 million annually thereafter through 2040.

You should also read Note 3 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2023 included elsewhere in this Quarterly Report.

-24-

Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risks relating to our operations result primarily from changes in interest rates and, with respect to our international operations, in foreign currency exchange rates. In the normal course of business, we also have risk related to commodity price changes for items such as natural gas. We employ established policies and procedures to manage our exposure to these risks. Interest rate, foreign currency and commodity pricing transactions are used only to the extent considered necessary to meet our objectives. We do not utilize derivative financial instruments for trading or other speculative purposes.

Information regarding our interest rate risk, foreign currency exchange rate risk and commodity pricing risk has been disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. Since such filing, other than the changes discussed in Note 7 to our Condensed Consolidated Financial Statements for the three months ended March 31, 2023 included elsewhere in this Quarterly Report, there has not been a material change to our interest rate risk, foreign currency exchange rate risk or commodity pricing risk or to our policies and procedures to manage our exposure to these risks.

Item 4.  CONTROLS AND PROCEDURES

As required by Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based upon that evaluation, as of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that our disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including the Principal Executive Officer and the Principal Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal controls over financial reporting during the period covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, these internal controls.

-25-

Part II.  Other Information

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

(c) Purchases of Equity Securities By the Issuer and Affiliated Purchasers

The following table provides information about shares of our common stock that we repurchased during the first quarter of 2023:

ISSUER PURCHASES OF EQUITY SECURITIES
				(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	(d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions) (1)
	(a) Total Number of Shares Purchased
		(b) Average Price Paid per Share
January 1-31, 2023	—	$	—	—	$267.9
February 1-28, 2023	—	$	—	—	$267.9
March 1-31, 2023	92,996	$	51.60	92,996	$263.1
Total	92,996	$	51.60	92,996	$263.1

(1) On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026, of which we had repurchased approximately $32.1 million of our common stock prior to the first quarter of 2023.

-26-

Item 6.  Exhibits

Exhibit Number	Description
22	Subsidiary Guarantors and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 filed with our Annual Report on Form 10-K for the year ended December 31, 2022, Commission File No. 001-41459).
10.1	Silgan Holdings Inc. Second Amended and Restated 2004 Stock Incentive Plan (incorporated by reference to Appendix A of our Definitive Proxy Statement on Schedule 14A, dated April 20, 2023, Commission File No. 001-41459).
*31.1	Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.
*31.2	Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.
*32.1	Certification by the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act.
*32.2	Certification by the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

___________________ 

*Filed herewith.

-27-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	SILGAN HOLDINGS INC.
Dated: May 3, 2023	/s/ Kimberly I. Ulmer
	Kimberly I. Ulmer
	Senior Vice President,
	Chief Financial Officer and Treasurer
	(Principal Financial and
	Accounting Officer)

-28-

EX-31.1

Exhibit 31.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT

I, Adam J. Greenlee, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2023 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 3, 2023	/s/ Adam J. Greenlee
	Adam J. Greenlee
	President and
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT

I, Kimberly I. Ulmer, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2023 of Silgan Holdings Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:  May 3, 2023	/s/ Kimberly I. Ulmer
	Kimberly I. Ulmer
	Senior Vice President,
	Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of Silgan Holdings Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Adam J. Greenlee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Adam J. Greenlee

Adam J. Greenlee

President and

Chief Executive Officer

May 3, 2023

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the Quarterly Report of Silgan Holdings Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Kimberly I. Ulmer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Kimberly I. Ulmer

Kimberly I. Ulmer

Senior Vice President,

Chief Financial Officer and Treasurer

May 3, 2023

A signed original of this written statement required by Section 906 has been provided to Silgan Holdings Inc. and will be retained by Silgan Holdings Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2023	Apr. 28, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-41459
Entity Registrant Name	SILGAN HOLDINGS INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1269834
Entity Address, Address Line One	4 Landmark Square
Entity Address, City or Town	Stamford,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06901
City Area Code	203
Local Phone Number	975-7110
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	SLGN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		110,252,446
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000849869
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 501,060	$ 585,622	$ 259,564
Trade accounts receivable, net	936,048	657,968	852,876
Inventories	1,055,079	769,403	1,018,685
Prepaid expenses and other current assets	132,822	119,659	150,646
Total current assets	2,625,009	2,132,652	2,281,771
Property, plant and equipment, net	1,930,003	1,931,497	1,979,681
Goodwill	2,001,753	1,984,952	2,024,340
Other intangible assets, net	755,883	763,812	817,450
Other assets, net	549,074	532,844	607,168
Assets, total	7,861,722	7,345,757	7,710,410
Current liabilities:
Revolving loans and current portion of long-term debt	784,795	80,061	539,134
Trade accounts payable	716,487	974,030	850,532
Accrued payroll and related costs	101,881	98,914	109,096
Accrued liabilities	240,952	284,855	218,194
Total current liabilities	1,844,115	1,437,860	1,716,956
Long-term debt	3,370,346	3,345,381	3,445,633
Deferred income taxes	389,010	388,677	433,843
Other liabilities	476,961	455,583	475,739
Stockholders’ equity:
Common stock	1,751	1,751	1,751
Paid-in capital	342,157	339,839	328,201
Retained earnings	3,013,104	2,961,079	2,758,697
Accumulated other comprehensive loss	(324,570)	(345,310)	(244,642)
Treasury stock	(1,251,152)	(1,239,103)	(1,205,768)
Total stockholders’ equity	1,781,290	1,718,256	1,638,239
Liabilities and equity, total	$ 7,861,722	$ 7,345,757	$ 7,710,410

XML

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net sales	$ 1,418,281	$ 1,441,886
Cost of goods sold	1,180,316	1,208,433
Gross profit	237,965	233,453
Selling, general and administrative expenses	101,330	100,011
Rationalization charges	4,121	1,379
Other pension and postretirement expense (income)	1,286	(11,329)
Income before interest and income taxes	131,228	143,392
Interest and other debt expense before loss on early extinguishment of debt	36,766	29,349
Loss on early extinguishment of debt	0	1,481
Interest and other debt expense	36,766	30,830
Income before income taxes	94,462	112,562
Provision for income taxes	22,433	27,687
Net income	$ 72,029	$ 84,875
Earnings per share
Basic net income per share (usd per share)	$ 0.65	$ 0.77
Diluted net income per share (usd per share)	$ 0.65	$ 0.76
Weighted average number of shares
Basic (in shares)	110,219	110,600
Effect of dilutive securities (in shares)	630	793
Diluted (in shares)	110,849	111,393

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 72,029	$ 84,875
Other comprehensive income (loss), net of tax:
Changes in net prior service credit and actuarial losses	2,306	499
Change in fair value of derivatives	(1,287)	2,337
Foreign currency translation	19,721	12,350
Other comprehensive income	20,740	15,186
Comprehensive income	$ 92,769	$ 100,061

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows provided by (used in) operating activities:
Net income	$ 72,029	$ 84,875
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	66,176	69,067
Rationalization charges	4,121	1,379
Stock compensation expense	3,681	4,879
Loss on early extinguishment of debt	0	1,481
Other changes that provided (used) cash, net of effects from acquisitions:
Trade accounts receivable, net	(271,224)	(141,113)
Inventories	(279,982)	(222,137)
Trade accounts payable	(176,147)	(29,881)
Accrued liabilities	(49,812)	(23,291)
Other, net	(616)	(12,660)
Net cash (used in) operating activities	(631,774)	(267,401)
Cash flows provided by (used in) investing activities:
Purchase of businesses, net of cash acquired	0	(1,333)
Capital expenditures	(67,871)	(68,491)
Other, net	880	(203)
Net cash (used in) investing activities	(66,991)	(70,027)
Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	783,454	544,624
Repayments under revolving loans	(29,100)	(24,408)
Proceeds from issuance of long-term debt	2,146	0
Repayments of long-term debt	(50,705)	(300,000)
Changes in outstanding checks - principally vendors	(61,433)	(225,863)
Dividends paid on common stock	(20,575)	(18,722)
Repurchase of common stock	(13,412)	(11,474)
Net cash provided by (used in) financing activities	610,375	(35,843)
Effect of exchange rate changes on cash and cash equivalents	3,828	1,396
Cash and cash equivalents:
Net (decrease)	(84,562)	(371,875)
Balance at beginning of year	585,622	631,439
Balance at end of period	501,060	259,564
Interest paid, net	34,764	33,116
Income taxes paid, net	$ 20,086	$ 6,718

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Paid-in capital	Retained earnings	Accumulated other comprehensive loss	Treasury stock
Beginning balance at Dec. 31, 2021		$ 1,751	$ 325,448	$ 2,691,745	$ (259,828)	$ (1,196,420)
Beginning balance (in shares) at Dec. 31, 2021		110,410
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		390
Repurchase of common stock (in shares)		0
Stock compensation expense			4,879
Net issuance of treasury stock for vested restricted stock units			(2,126)			(9,348)
Net income	$ 84,875			84,875
Dividends declared on common stock				(17,923)
Other comprehensive income					15,186
Repurchases of common stock						0
Ending balance at Mar. 31, 2022	$ 1,638,239	$ 1,751	328,201	2,758,697	(244,642)	(1,205,768)
Ending balance (in shares) at Mar. 31, 2022		110,800
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.16
Beginning balance at Dec. 31, 2022	$ 1,718,256	$ 1,751	339,839	2,961,079	(345,310)	(1,239,103)
Beginning balance (in shares) at Dec. 31, 2022		110,079
Increase (Decrease) in Stockholders' Equity
Net issuance of treasury stock for vested restricted stock units (in shares)		266
Repurchase of common stock (in shares)		(93)
Stock compensation expense			3,681
Net issuance of treasury stock for vested restricted stock units			(1,363)			(7,249)
Net income	72,029			72,029
Dividends declared on common stock				(20,004)
Other comprehensive income					20,740
Repurchases of common stock						(4,800)
Ending balance at Mar. 31, 2023	$ 1,781,290	$ 1,751	$ 342,157	$ 3,013,104	$ (324,570)	$ (1,251,152)
Ending balance (in shares) at Mar. 31, 2023		110,252
Increase (Decrease) in Stockholders' Equity
Dividends declared on common stock per share (usd per share)	$ 0.18

XML

Significant Accounting Policies

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2022 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.

XML

Revenue

3 Months Ended

Mar. 31, 2023

Revenue Recognition [Abstract]

Revenue

Revenue

The following tables present our revenues disaggregated by reportable segment and geography as they best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenues by segment for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Dispensing and Specialty Closures	$	579,932	$	597,927
Metal Containers	670,096		650,726
Custom Containers	168,253		193,233
	$	1,418,281	$	1,441,886

Revenues by geography for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
North America	$	1,056,526	$	1,086,224
Europe and other	361,755		355,662
	$	1,418,281	$	1,441,886

Our contract assets primarily consist of unbilled accounts receivable related to over time revenue recognition and were $108.5 million, $99.1 million, and $110.2 million as of March 31, 2023 and 2022 and December 31, 2022, respectively. Unbilled receivables are included in trade accounts receivable, net on our Condensed Consolidated Balance Sheets.

XML

Rationalization Charges

3 Months Ended

Mar. 31, 2023

Restructuring and Related Activities [Abstract]

Rationalization Charges

Rationalization Charges

We continually evaluate cost reduction opportunities across each of our segments, including rationalizations of our existing facilities through plant closings and downsizings. We use a disciplined approach to identify opportunities that generate attractive cash returns. Rationalization charges by segment for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Dispensing and Specialty Closures	$	114	$	—
Metal Containers	3,903		1,274
Custom Containers	104		105
	$	4,121	$	1,379

Activity in reserves for our rationalization plans were as follows:

	Employee Severance and Benefits		Plant Exit Costs		Total
	(Dollars in thousands)
Balance at December 31, 2022	$	31,641	$	159	$	31,800
Charged to expense	1,797		2,324		4,121
Utilized and currency translation	(2,813)		(2,319)		(5,132)
Balance at March 31, 2023	$	30,625	$	164	$	30,789

Rationalization reserves as of March 31, 2023 were recorded in our Condensed Consolidated Balance Sheet as accrued liabilities of $3.2 million and other liabilities of $27.6 million. Excluding the impact of our withdrawal from the Central States, Southeast and Southwest Areas Pension Plan, or the Central States Pension Plan, in 2019, remaining expenses and cash expenditures for our rationalization plans are expected to be $1.7 million and $5.4 million, respectively. Remaining expenses for the accretion of interest for the withdrawal liability related to the Central States Pension Plan are expected to average approximately $0.9 million per year and be recognized annually through 2040, and remaining cash expenditures for the withdrawal liability related to the Central States Pension Plan are expected to be approximately $0.8 million in 2023 and $2.6 million annually thereafter through 2040.

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss is reported in our Condensed Consolidated Statements of Stockholders’ Equity.  Amounts included in accumulated other comprehensive loss, net of tax, were as follows:

 

	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2022	$	(156,733)	$	(772)	$	(187,805)	$	(345,310)
Other comprehensive income before reclassifications	—		(1,714)		19,721		18,007
Amounts reclassified from accumulated other     comprehensive loss	2,306		427		—		2,733
Other comprehensive income	2,306		(1,287)		19,721		20,740
Balance at March 31, 2023	$	(154,427)	$	(2,059)	$	(168,084)	$	(324,570)

The amounts reclassified to earnings from the unrecognized net defined benefit plan costs component of accumulated other comprehensive loss for the three months ended March 31, 2023 were net (losses) of $(2.6) million, excluding income tax benefits of $0.3 million. These net (losses) consisted of amortization of net actuarial (losses) of $(2.8) million and amortization of net prior service credit of $0.2 million. Amortization of net actuarial losses and net prior service credit was recorded in other pension and postretirement income in our Condensed Consolidated Statements of Income. See Note 10 for further information.

The amounts reclassified to earnings from the change in fair value of derivatives component of accumulated other comprehensive loss for the three months ended March 31, 2023 were not significant.

Other comprehensive loss before reclassifications related to foreign currency translation for the three months ended March 31, 2023 consisted of (i) foreign currency gains related to translation of quarter end financial statements of foreign subsidiaries utilizing a functional currency other than the U.S. dollar of $25.6 million, (ii) foreign currency gains related to intra-entity foreign currency transactions that are of a long-term investment nature of $0.8 million, and (iii) foreign currency (losses) related to our net investment hedges of $(8.8) million, excluding an income tax benefit of $2.1 million. See Note 7 for further discussion.

XML

Inventories

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of the following: 

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(Dollars in thousands)
Raw materials	$	498,580	$	295,713	$	409,349
Work-in-process	254,373		263,878		218,691
Finished goods	630,233		607,087		469,212
Other	16,205		14,787		16,463
	1,399,391		1,181,465		1,113,715
Adjustment to value inventory at cost on the LIFO method	(344,312)		(162,780)		(344,312)
	$	1,055,079	$	1,018,685	$	769,403

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Long-Term Debt

Long-Term Debt

Long-term debt consisted of the following: 

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	755,000	$	508,000	$	—
U.S. term loans	950,000		1,000,000		1,000,000
Other foreign bank revolving and term loans	51,840		50,014		49,673
Total bank debt	1,756,840		1,558,014		1,049,673
3¼% Senior Notes	706,160		723,190		693,680
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	543,200		556,300		533,600
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	65,050		67,714		65,667
Total debt - principal	4,171,250		4,005,218		3,442,620
Less unamortized debt issuance costs and debt discount	16,109		20,451		17,178
Total debt	4,155,141		3,984,767		3,425,442
Less current portion	784,795		539,134		80,061
	$	3,370,346	$	3,445,633	$	3,345,381

At March 31, 2023, the current portion of long-term debt consisted of $755.0 million of U.S. revolving loans under our amended and restated senior secured credit facility, as amended, or the Credit Agreement, $27.4 million of other foreign bank revolving and term loans and $2.4 million of finance leases.

XML

Financial Instruments

3 Months Ended

Mar. 31, 2023

Investments, All Other Investments [Abstract]

Financial Instruments

Financial Instruments

The financial instruments recorded in our Condensed Consolidated Balance Sheets include cash and cash equivalents, trade accounts receivable, trade accounts payable, debt obligations and swap agreements. Due to their short-term maturity, the carrying amounts of trade accounts receivable and trade accounts payable approximate their fair market values. The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2023:

	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	501,060	$	501,060
Liabilities:
Bank debt	$	1,756,840	$	1,756,840
3¼% Senior Notes	706,160		689,558
4⅛% Senior Notes	599,346		564,720
2¼% Senior Notes	543,200		459,971
1.4% Senior Secured Notes	499,836		445,715

Fair Value Measurements

GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). GAAP classifies the inputs used to measure fair value into a hierarchy consisting of three levels. Level 1 inputs represent unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs represent unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability. Level 3 inputs represent unobservable inputs for the asset or liability. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

Financial Instruments Measured at Fair Value

The financial assets and liabilities that were measured on a recurring basis at March 31, 2023 consisted of our cash and cash equivalents and derivative instruments. We measured the fair value of cash and cash equivalents using Level 1 inputs. We measured the fair value of our derivative instruments using the income approach. The fair value of our derivative instruments reflects the estimated amounts that we would pay or receive based on the present value of the expected cash flows derived from market interest rates and prices. As such, these derivative instruments were classified within Level 2.

Financial Instruments Not Measured at Fair Value

Our bank debt, 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were recorded at historical amounts in our Condensed Consolidated Balance Sheets, as we have not elected to measure them at fair value. We measured the fair value of our variable rate bank debt using the market approach based on Level 2 inputs. Fair values of the 3¼% Senior Notes, 4⅛% Senior Notes, 2¼% Senior Notes and 1.4% Senior Secured Notes were estimated based on quoted market prices, a Level 1 input.

Derivative Instruments and Hedging Activities

Our derivative financial instruments were recorded in the Condensed Consolidated Balance Sheets at their fair values. Changes in fair values of derivatives are recorded in each period in earnings or comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and, if it is, the type of hedge transaction.

We utilize certain derivative financial instruments to manage a portion of our interest rate and natural gas cost exposures. We generally limit our use of derivative financial instruments to interest rate and natural gas swap agreements. We do not engage in trading or other speculative uses of these financial instruments. For a financial instrument to qualify as a hedge, we must be exposed to interest rate or price risk, and the financial instrument must reduce the exposure and be designated as a hedge. Financial instruments qualifying for hedge accounting must maintain a high correlation between the hedging instrument and the item being hedged, both at inception and throughout the hedged period.

We also utilize certain internal hedging strategies to minimize our foreign currency exchange rate risk. Net investment hedges that qualify for hedge accounting result in the recognition of foreign currency gains or losses, net of tax, in accumulated other comprehensive loss. 

Interest Rate Swap Agreements

We had two U.S. dollar interest rate swap agreements, each for $50.0 million notional principal amount, to manage a portion of our exposure to interest rate fluctuations, with a fixed rate of 2.878 percent, that matured on March 24, 2023. In March 2023, we entered into four U.S. dollar interest rate swap agreements, each for $75.0 million notional principal amount, to manage a portion of our exposure to interest rate fluctuations. These agreements have a fixed rate ranging from 3.930 percent to 3.942 percent, mature on April 3, 2026 and were entered into with financial institutions which are expected to fully perform under the terms thereof. The difference between amounts to be paid or received on our interest rate swap agreements is recorded in interest and other debt expense in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2023. The total fair value of our interest rate swaps agreements in effect at March 31, 2023 was not significant.

Natural Gas Swap Agreements

We have entered into natural gas swap agreements to manage a portion of our exposure to fluctuations in natural gas prices. The difference between amounts to be paid or received on our natural gas swap agreements is recorded in cost of goods sold in our Condensed Consolidated Statements of Income and was not significant for the three months ended March 31, 2023. These agreements are with a financial institution which is expected to fully perform under the terms thereof. The total fair value of our natural gas swap agreements in effect at March 31, 2023 was not significant.

Foreign Currency Exchange Rate Risk

In an effort to minimize our foreign currency exchange rate risk, we have financed acquisitions of foreign operations primarily with borrowings denominated in Euros. In addition, where available, we have borrowed funds in local currency or implemented certain internal hedging strategies to minimize our foreign currency exchange rate risk related to foreign operations, including net investment hedges related to the 3¼% Senior Notes which are Euro denominated. Foreign currency (losses) related to our net investment hedges included in accumulated other comprehensive loss for the three months ended March 31, 2023 were $(8.8) million.

XML

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and ContingenciesWe are a party to other legal proceedings, contract disputes and claims arising in the ordinary course of our business. We are not a party to, and none of our properties are subject to, any pending legal proceedings which could have a material adverse effect on our business or financial condition.

XML

Supply Chain Finance Program	3 Months Ended
	Mar. 31, 2023
Payables and Accruals [Abstract]
Supply Chain Finance Program	Supply Chain Finance ProgramWe have a supply chain finance (“SCF”) program with a major global financial institution. Under this SCF program, qualifying suppliers may elect, but are not obligated, to sell their receivables from us to such financial institution. We agree to pay the financial institution the stated amount of invoices from our suppliers electing to participate on the original maturity dates of the invoices. We may terminate our agreement with the financial institution upon at least 30 days’ notice, and the financial institution may terminate our agreement upon at least 10 days’ notice. Additionally, suppliers who elect to participate in this SCF program may terminate their participation upon at least 30 days’ notice. The suppliers' invoices sold under this SCF program can be outstanding up to 210 days from the invoice date. Suppliers’ invoices included in this SCF program were $318.4 million, $372.2 million and $346.8 million at March 31, 2023 and 2022 and December 31, 2022, respectively, and were included in accounts payable in our Condensed Consolidated Balance Sheets.

XML

Retirement Benefits

3 Months Ended

Mar. 31, 2023

Retirement Benefits [Abstract]

Retirement Benefits

Retirement Benefits

The components of the net periodic pension benefit cost (credit) for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Service cost	$	2,229	$	3,300
Interest cost	8,709		5,159
Expected return on plan assets	(10,189)		(17,314)
Amortization of prior service cost	28		55
Amortization of actuarial losses	2,945		1,155
Net periodic benefit cost (credit)	$	3,722	$	(7,645)

The components of the net periodic other postretirement benefit credit for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Service cost	$	14	$	25
Interest cost	189		109
Amortization of prior service credit	(235)		(416)
Amortization of actuarial gains	(161)		(77)
Net periodic benefit credit	$	(193)	$	(359)

XML

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesSilgan and its subsidiaries file U.S. Federal income tax returns, as well as income tax returns in various states and foreign jurisdictions. The Internal Revenue Service, or IRS, has completed its review of the 2021 tax year with no change to our filed federal income tax return. We have been accepted into the Compliance Assurance Program for the 2022 and 2023 tax years which provides for the review by the IRS of tax matters relating to our tax return prior to filing.

XML

Treasury Stock

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Treasury Stock

Treasury Stock

On March 4, 2022, our Board of Directors authorized the repurchase by us of up to an aggregate of $300.0 million of our common stock by various means from time to time through and including December 31, 2026. During the three months ended March 31, 2023, we repurchased an aggregate of 92,996 shares of our common stock at an average price per share of $51.60, for a total purchase price of $4.8 million. At March 31, 2023, we had approximately $263.1 million remaining under this authorization for the repurchase of our common stock.

During the first three months of 2023, we issued 427,763 treasury shares which had an average cost of $3.19 per share for restricted stock units that vested during the period that had been previously issued under the Silgan Holdings Inc. Amended and Restated 2004 Stock Incentive Plan. In accordance with the applicable agreements for such restricted stock units, we repurchased 161,328 shares of our common stock at an average cost of $53.38 to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units.

We account for treasury shares using the first-in, first-out (FIFO) cost method. As of March 31, 2023, 64,860,050 shares of our common stock were held in treasury.

XML

Segment Information

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Information

Segment Information

We evaluate performance of our business segments and allocate resources based on the adjusted EBIT of our business segments. Adjusted EBIT is not a defined term under GAAP. We define adjusted EBIT as income before interest and income taxes excluding acquired intangible asset amortization expense, other pension expense (income) for U.S. pension plans, rationalization charges, the impact from charges for the write-up of acquired inventory required under purchase accounting, the charge for the European Commission settlement and costs attributed to announced acquisitions. We began using adjusted EBIT in 2023. Previously, we used segment income, without any adjustments, for our business segments. We have provided adjusted EBIT for 2022 below for comparative purposes. Adjusted EBIT should not be considered in isolation or as a substitute for income before interest and income taxes or any other financial data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies.

Reportable segment information for the three months ended March 31 was as follows:

	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three months ended March 31, 2023
Net sales	$	579,932	$	670,096	$	168,253	$	—	$	1,418,281
Adjusted EBIT	82,936		52,400		20,034		(5,966)		149,404
Depreciation	24,759		17,988		8,835		40		51,622
Three months ended March 31, 2022
Net sales	$	597,927	$	650,726	$	193,233	$	—	$	1,441,886
Adjusted EBIT	96,528		32,951		23,364		(6,624)		146,219
Depreciation	24,661		20,731		8,743		42		54,177

Total adjusted EBIT is reconciled to income before income taxes for the three months ended March 31 as follows:

	2023		2022
	(Dollars in thousands)
Total adjusted EBIT	$	149,404	$	146,219
Less:
Acquired intangible asset amortization expense	13,221		13,430
Other pension expense (income) for U.S. pension plans	834		(11,982)
Rationalization charges	4,121		1,379
Income before interest and income taxes	131,228		143,392
Less interest and other debt expense	36,766		30,830
Income before income taxes	$	94,462	$	112,562

Net sales and adjusted EBIT of our metal containers segment and of part of our dispensing and specialty closures segment are dependent, in part, upon the vegetable and fruit harvests in the United States and, to a lesser extent, in a variety of national growing regions in Europe. The size and quality of these harvests varies from year to year, depending in large part upon the weather conditions in applicable regions. Because of the seasonality of the harvests, we have historically experienced higher unit sales volume in the third quarter of our fiscal year and generated a disproportionate amount of our annual adjusted EBIT during that quarter.

XML

Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Silgan Holdings Inc., or Silgan, have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year.

The Condensed Consolidated Balance Sheet at December 31, 2022 has been derived from our audited consolidated financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

You should read the accompanying condensed consolidated financial statements in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue Recognition [Abstract]

Disaggregation of Revenue

Revenues by segment for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Dispensing and Specialty Closures	$	579,932	$	597,927
Metal Containers	670,096		650,726
Custom Containers	168,253		193,233
	$	1,418,281	$	1,441,886

Revenues by geography for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
North America	$	1,056,526	$	1,086,224
Europe and other	361,755		355,662
	$	1,418,281	$	1,441,886

XML

Rationalization Charges (Tables)

3 Months Ended

Mar. 31, 2023

Restructuring and Related Activities [Abstract]

Activity in Rationalization Plan Reserves

Rationalization charges by segment for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Dispensing and Specialty Closures	$	114	$	—
Metal Containers	3,903		1,274
Custom Containers	104		105
	$	4,121	$	1,379

Activity in reserves for our rationalization plans were as follows:

	Employee Severance and Benefits		Plant Exit Costs		Total
	(Dollars in thousands)
Balance at December 31, 2022	$	31,641	$	159	$	31,800
Charged to expense	1,797		2,324		4,121
Utilized and currency translation	(2,813)		(2,319)		(5,132)
Balance at March 31, 2023	$	30,625	$	164	$	30,789

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Amounts Included in Accumulated Other Comprehensive Loss, Net of Tax

Amounts included in accumulated other comprehensive loss, net of tax, were as follows: 

	Unrecognized Net Defined Benefit Plan Costs		Change in Fair Value of Derivatives		Foreign Currency Translation		Total
	(Dollars in thousands)
Balance at December 31, 2022	$	(156,733)	$	(772)	$	(187,805)	$	(345,310)
Other comprehensive income before reclassifications	—		(1,714)		19,721		18,007
Amounts reclassified from accumulated other     comprehensive loss	2,306		427		—		2,733
Other comprehensive income	2,306		(1,287)		19,721		20,740
Balance at March 31, 2023	$	(154,427)	$	(2,059)	$	(168,084)	$	(324,570)

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2023

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following: 

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(Dollars in thousands)
Raw materials	$	498,580	$	295,713	$	409,349
Work-in-process	254,373		263,878		218,691
Finished goods	630,233		607,087		469,212
Other	16,205		14,787		16,463
	1,399,391		1,181,465		1,113,715
Adjustment to value inventory at cost on the LIFO method	(344,312)		(162,780)		(344,312)
	$	1,055,079	$	1,018,685	$	769,403

XML

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Long-term Debt

Long-term debt consisted of the following: 

	March 31, 2023		March 31, 2022		Dec. 31, 2022
	(Dollars in thousands)
Bank debt
Bank revolving loans	$	755,000	$	508,000	$	—
U.S. term loans	950,000		1,000,000		1,000,000
Other foreign bank revolving and term loans	51,840		50,014		49,673
Total bank debt	1,756,840		1,558,014		1,049,673
3¼% Senior Notes	706,160		723,190		693,680
4⅛% Senior Notes	600,000		600,000		600,000
2¼% Senior Notes	543,200		556,300		533,600
1.4% Senior Secured Notes	500,000		500,000		500,000
Finance leases	65,050		67,714		65,667
Total debt - principal	4,171,250		4,005,218		3,442,620
Less unamortized debt issuance costs and debt discount	16,109		20,451		17,178
Total debt	4,155,141		3,984,767		3,425,442
Less current portion	784,795		539,134		80,061
	$	3,370,346	$	3,445,633	$	3,345,381

XML

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2023

Investments, All Other Investments [Abstract]

Summary of Carrying Amounts and Estimated Fair Values of Other Financial Instruments

The following table summarizes the carrying amounts and estimated fair values of our other financial instruments at March 31, 2023:

	Carrying Amount		Fair Value
	(Dollars in thousands)
Assets:
Cash and cash equivalents	$	501,060	$	501,060
Liabilities:
Bank debt	$	1,756,840	$	1,756,840
3¼% Senior Notes	706,160		689,558
4⅛% Senior Notes	599,346		564,720
2¼% Senior Notes	543,200		459,971
1.4% Senior Secured Notes	499,836		445,715

XML

Retirement Benefits (Tables)

3 Months Ended

Mar. 31, 2023

Retirement Benefits [Abstract]

Components of Net Periodic Benefit Cost (Credit)

The components of the net periodic pension benefit cost (credit) for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Service cost	$	2,229	$	3,300
Interest cost	8,709		5,159
Expected return on plan assets	(10,189)		(17,314)
Amortization of prior service cost	28		55
Amortization of actuarial losses	2,945		1,155
Net periodic benefit cost (credit)	$	3,722	$	(7,645)

The components of the net periodic other postretirement benefit credit for the three months ended March 31 were as follows:

	2023		2022
	(Dollars in thousands)
Service cost	$	14	$	25
Interest cost	189		109
Amortization of prior service credit	(235)		(416)
Amortization of actuarial gains	(161)		(77)
Net periodic benefit credit	$	(193)	$	(359)

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Reportable Operating Segment Information

Reportable segment information for the three months ended March 31 was as follows:

	Dispensing and Specialty Closures		Metal Containers		Custom Containers		Corporate		Total
	(Dollars in thousands)
Three months ended March 31, 2023
Net sales	$	579,932	$	670,096	$	168,253	$	—	$	1,418,281
Adjusted EBIT	82,936		52,400		20,034		(5,966)		149,404
Depreciation	24,759		17,988		8,835		40		51,622
Three months ended March 31, 2022
Net sales	$	597,927	$	650,726	$	193,233	$	—	$	1,441,886
Adjusted EBIT	96,528		32,951		23,364		(6,624)		146,219
Depreciation	24,661		20,731		8,743		42		54,177

Reconciliation of Adjusted EBIT to Income before Income Taxes

Total adjusted EBIT is reconciled to income before income taxes for the three months ended March 31 as follows:

	2023		2022
	(Dollars in thousands)
Total adjusted EBIT	$	149,404	$	146,219
Less:
Acquired intangible asset amortization expense	13,221		13,430
Other pension expense (income) for U.S. pension plans	834		(11,982)
Rationalization charges	4,121		1,379
Income before interest and income taxes	131,228		143,392
Less interest and other debt expense	36,766		30,830
Income before income taxes	$	94,462	$	112,562

XML

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 1,418,281	$ 1,441,886
Trade Accounts Receivable | Unbilled Accounts Receivable
Segment Reporting Information [Line Items]
Contract assets	108,500	99,100	$ 110,200
North America
Segment Reporting Information [Line Items]
Net sales	1,056,526	1,086,224
Europe and other
Segment Reporting Information [Line Items]
Net sales	361,755	355,662
Dispensing and Specialty Closures
Segment Reporting Information [Line Items]
Net sales	579,932	597,927
Metal Containers
Segment Reporting Information [Line Items]
Net sales	670,096	650,726
Custom Containers
Segment Reporting Information [Line Items]
Net sales	$ 168,253	$ 193,233

XML

Rationalization Charges - Rationalization Charges by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Cost and Reserve [Line Items]
Rationalization charges	$ 4,121	$ 1,379
Dispensing and Specialty Closures
Restructuring Cost and Reserve [Line Items]
Rationalization charges	114	0
Metal Containers
Restructuring Cost and Reserve [Line Items]
Rationalization charges	3,903	1,274
Custom Containers
Restructuring Cost and Reserve [Line Items]
Rationalization charges	$ 104	$ 105

XML

Rationalization Charges - Activity in Rationalization Plan Reserves (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restructuring Reserve [Roll Forward]
Balance at December 31, 2022	$ 31,800
Charged to expense	4,121	$ 1,379
Utilized and currency translation	(5,132)
Balance at March 31, 2023	30,789
Employee Severance and Benefits
Restructuring Reserve [Roll Forward]
Balance at December 31, 2022	31,641
Charged to expense	1,797
Utilized and currency translation	(2,813)
Balance at March 31, 2023	30,625
Plant Exit Costs
Restructuring Reserve [Roll Forward]
Balance at December 31, 2022	159
Charged to expense	2,324
Utilized and currency translation	(2,319)
Balance at March 31, 2023	$ 164

XML

Rationalization Charges - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 30,789	$ 31,800
Other Restructuring | Rationalization Plan
Restructuring Cost and Reserve [Line Items]
Remaining expenses	1,700
Remaining cash expenditures	5,400
Next Fiscal Year Following Current Fiscal Year | Central States Pension Plan Withdrawal
Restructuring Cost and Reserve [Line Items]
Remaining cash expenditures	800
Annually Through 2040 | Central States Pension Plan withdrawal
Restructuring Cost and Reserve [Line Items]
Remaining cash expenditures	2,600
Accretion expense	900
Accrued Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	3,200
Other Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	$ 27,600

XML

Accumulated Other Comprehensive Loss - Amounts Included in Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	$ 1,718,256
Other comprehensive income before reclassifications	18,007
Amounts reclassified from accumulated other comprehensive loss	2,733
Other comprehensive income	20,740	$ 15,186
Ending balance	1,781,290	1,638,239
Accumulated other comprehensive loss
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(345,310)	(259,828)
Ending balance	(324,570)	$ (244,642)
Unrecognized Net Defined Benefit Plan Costs
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(156,733)
Other comprehensive income before reclassifications	0
Amounts reclassified from accumulated other comprehensive loss	2,306
Other comprehensive income	2,306
Ending balance	(154,427)
Change in Fair Value of Derivatives
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(772)
Other comprehensive income before reclassifications	(1,714)
Amounts reclassified from accumulated other comprehensive loss	427
Other comprehensive income	(1,287)
Ending balance	(2,059)
Foreign Currency Translation
Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(187,805)
Other comprehensive income before reclassifications	19,721
Amounts reclassified from accumulated other comprehensive loss	0
Other comprehensive income	19,721
Ending balance	$ (168,084)

XML

Accumulated Other Comprehensive Loss - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Unrecognized Net Defined Benefit Plan Costs
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive (loss) reclassification adjustment from AOCI	$ (2.6)
Benefit for income taxes	0.3
Amortization of net actuarial (losses), before tax	(2.8)
Net prior service credit arising during period, before tax	0.2
Accumulated Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency gains (losses)	25.6
Foreign currency transaction and translation gain (loss) arising during period related to intra-entity transactions of a long-term investment nature, net of tax	0.8
Foreign currency (losses) gains of net investment hedges included in accumulated other comprehensive loss	(8.8)
Foreign currency translation, tax benefit (provision) related to net investment hedges	$ 2.1

XML

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 498,580	$ 409,349	$ 295,713
Work-in-process	254,373	218,691	263,878
Finished goods	630,233	469,212	607,087
Other	16,205	16,463	14,787
Inventories, gross	1,399,391	1,113,715	1,181,465
Adjustment to value inventory at cost on the LIFO method	(344,312)	(344,312)	(162,780)
Inventories	$ 1,055,079	$ 769,403	$ 1,018,685

XML

Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Debt Instrument [Line Items]
Total debt - principal	$ 4,171,250	$ 3,442,620	$ 4,005,218
Less unamortized debt issuance costs and debt discount	16,109	17,178	20,451
Debt long term and short term less unamortized debt issuance costs and debt discount	4,155,141	3,425,442	3,984,767
Less current portion	784,795	80,061	539,134
Long-term debt	3,370,346	3,345,381	3,445,633
Bank debt
Debt Instrument [Line Items]
Total debt - principal	1,756,840	1,049,673	1,558,014
Finance Leases
Debt Instrument [Line Items]
Total debt - principal	65,050	65,667	67,714
Bank Revolving Loans | Bank debt
Debt Instrument [Line Items]
Total debt - principal	755,000	0	508,000
Less current portion	755,000
U S Term Loans | Bank debt
Debt Instrument [Line Items]
Total debt - principal	950,000	1,000,000	1,000,000
Other Foreign Bank Revolving and Term Loans | Bank debt
Debt Instrument [Line Items]
Total debt - principal	51,840	49,673	50,014
Less current portion	27,400
Senior Notes | 3¼% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 706,160	693,680	723,190
Senior note interest rate	3.25%
Senior Notes | 4⅛% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 600,000	600,000	600,000
Senior note interest rate	4.125%
Senior Notes | 2¼% Senior Notes
Debt Instrument [Line Items]
Total debt - principal	$ 543,200	533,600	556,300
Senior note interest rate	2.25%
Senior Notes | 1.4% Senior Secured Notes
Debt Instrument [Line Items]
Total debt - principal	$ 500,000	$ 500,000	$ 500,000
Senior note interest rate	1.40%
Finance Leases
Debt Instrument [Line Items]
Less current portion	$ 2,400

XML

Long-Term Debt - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Debt Instrument [Line Items]
Long-term debt, current maturities	$ 784,795	$ 80,061	$ 539,134
Finance Leases
Debt Instrument [Line Items]
Long-term debt, current maturities	2,400
Bank debt | Other Foreign Bank Revolving and Term Loans
Debt Instrument [Line Items]
Long-term debt, current maturities	$ 27,400

XML

Financial Instruments - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) $ in Thousands	Mar. 31, 2023 USD ($)
Senior Notes | 3¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	3.25%
Senior Notes | 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	4.125%
Senior Notes | 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	2.25%
Senior Notes | 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior note interest rate	1.40%
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 501,060
Carrying Amount | Bank debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	1,756,840
Carrying Amount | Senior Notes | 3¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	706,160
Carrying Amount | Senior Notes | 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	599,346
Carrying Amount | Senior Notes | 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	543,200
Carrying Amount | Senior Notes | 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	499,836
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	501,060
Fair Value | Bank debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	1,756,840
Fair Value | Senior Notes | 3¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	689,558
Fair Value | Senior Notes | 4⅛% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	564,720
Fair Value | Senior Notes | 2¼% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	459,971
Fair Value | Senior Notes | 1.4% Senior Secured Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Bank debt	$ 445,715

XML

Financial Instruments - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 24, 2023
USD Interest Rate Swap Contract, Maturity Date March 24, 2023
Derivative [Line Items]
Fixed interest rate		2.878%
USD Interest Rate Swap Contract One, Maturity Date March 24, 2023
Derivative [Line Items]
Derivative, notional amount		$ 50,000,000
USD Interest Rate Swap Contract Two, Maturity Date March 24, 2023
Derivative [Line Items]
Derivative, notional amount		$ 50,000,000
USD Interest Rate Swap, Maturity Date April 3, 2026 | Minimum
Derivative [Line Items]
Fixed interest rate	3.93%
USD Interest Rate Swap, Maturity Date April 3, 2026 | Maximum
Derivative [Line Items]
Fixed interest rate	3.942%
USD Interest Rate Swap Contract One, Maturity Date April 3, 2026
Derivative [Line Items]
Derivative, notional amount	$ 75,000,000
USD Interest Rate Swap Contract Two, Maturity Date April 3, 2026
Derivative [Line Items]
Derivative, notional amount	75,000,000
USD Interest Rate Swap Contract Three, Maturity Date April 3, 2026
Derivative [Line Items]
Derivative, notional amount	75,000,000
USD Interest Rate Swap Contract Four, Maturity Date April 3, 2026
Derivative [Line Items]
Derivative, notional amount	75,000,000
Accumulated Translation Adjustment
Derivative [Line Items]
Foreign currency (losses) gains of net investment hedges included in accumulated other comprehensive loss	$ (8,800,000)

XML

Supply Chain Finance Program (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Payables and Accruals [Abstract]
Termination notice period (at least)	30 days
Termination notice period by financial institution (at least)	10 days
Supply chain finance program, payment period (up to)	210 days
Supplier chain finance program obligation, current	$ 318.4	$ 346.8	$ 372.2

XML

Retirement Benefits - Components of Net Periodic Benefit Cost (Credit) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Pension Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 2,229	$ 3,300
Interest cost	8,709	5,159
Expected return on plan assets	(10,189)	(17,314)
Amortization of prior service cost	28	55
Amortization of actuarial losses (gains)	2,945	1,155
Net periodic benefit cost (credit)	3,722	(7,645)
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	14	25
Interest cost	189	109
Amortization of prior service cost	(235)	(416)
Amortization of actuarial losses (gains)	(161)	(77)
Net periodic benefit cost (credit)	$ (193)	$ (359)

XML

Treasury Stock (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 04, 2022
Equity, Class of Treasury Stock [Line Items]
Treasury stock (in shares)	64,860,050
2022 BOD Authorized Common Stock Repurchase
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, additional repurchase authorization		$ 300,000,000.0
Repurchase of common stock (in shares)	92,996
Average cost per share of treasury stock acquired (usd per share)	$ 51.60
Stock repurchase price	$ 4,800,000
Remaining authorized repurchase amount	$ 263,100,000
2004 Amended and Restated Stock Incentive Plan
Equity, Class of Treasury Stock [Line Items]
Average cost per share of treasury stock acquired (usd per share)	$ 53.38
Treasury shares issued for restricted stock units that vested during the period (in shares)	427,763
Average cost of treasury shares that were issued for restricted stock units that vested during the period (usd per share)	$ 3.19
Shares repurchased to satisfy minimum employee withholding tax requirements resulting from the vesting of such restricted stock units (in shares)	161,328

XML

Segment Information - Reportable Business Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 1,418,281	$ 1,441,886
Adjusted EBIT	149,404	146,219
Depreciation	51,622	54,177
Dispensing and Specialty Closures
Segment Reporting Information [Line Items]
Net sales	579,932	597,927
Adjusted EBIT	82,936	96,528
Depreciation	24,759	24,661
Metal Containers
Segment Reporting Information [Line Items]
Net sales	670,096	650,726
Adjusted EBIT	52,400	32,951
Depreciation	17,988	20,731
Custom Containers
Segment Reporting Information [Line Items]
Net sales	168,253	193,233
Adjusted EBIT	20,034	23,364
Depreciation	8,835	8,743
Corporate
Segment Reporting Information [Line Items]
Net sales	0	0
Adjusted EBIT	(5,966)	(6,624)
Depreciation	$ 40	$ 42

XML

Segment Information - Reconciliation of Adjusted EBIT to Income before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total adjusted EBIT	$ 149,404	$ 146,219
Less:
Other pension expense (income) for U.S. pension plans	1,286	(11,329)
Rationalization charges	4,121	1,379
Income before interest and income taxes	131,228	143,392
Less interest and other debt expense	36,766	30,830
Income before income taxes	94,462	112,562
Segment Reconciling Items
Less:
Acquired intangible asset amortization expense	13,221	13,430
Other pension expense (income) for U.S. pension plans	834	(11,982)
Rationalization charges	$ 4,121	$ 1,379